Citadel Advisors’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16M Buy
671,900
+489,200
+268% +$9.39M ﹤0.01% 2879
2026
Q1
$3.22M Sell
182,700
-280,000
-61% -$5.62M ﹤0.01% 5119
2025
Q4
$9.14M Sell
462,700
-90,100
-16% -$1.62M ﹤0.01% 3386
2025
Q3
$9.65M Buy
552,800
+467,000
+544% +$6.92M ﹤0.01% 3332
2025
Q2
$1.2M Buy
85,800
+4,300
+5% +$69.2K ﹤0.01% 6694
2025
Q1
$1.52M Sell
81,500
-64,900
-44% -$968K ﹤0.01% 6077
2024
Q4
$1.65M Buy
+146,400
New +$1.71M ﹤0.01% 6030
2024
Q3
Sell
-13,000
Closed -$102K 14157
2024
Q2
$102K Buy
13,000
+8,500
+189% +$55.5K ﹤0.01% 10901
2024
Q1
$22.3K Buy
4,500
+3,100
+221% +$19.8K ﹤0.01% 12934
2023
Q4
$12.1K Sell
1,400
-8,500
-86% -$62.2K ﹤0.01% 13011
2023
Q3
$68.7K Buy
9,900
+1,100
+13% +$6.64K ﹤0.01% 11344
2023
Q2
$50.6K Buy
+8,800
New +$56.9K ﹤0.01% 11790
2023
Q1
Sell
-21,900
Closed -$258K 14654
2022
Q4
$258K Sell
21,900
-14,900
-40% -$181K ﹤0.01% 9632
2022
Q3
$436K Buy
+36,800
New +$537K ﹤0.01% 8768
2021
Q3
Sell
-33,100
Closed -$774K 13738
2021
Q2
$774K Buy
+33,100
New +$805K ﹤0.01% 9030

Other funds holding ALHC

Citadel Advisors's ALHC Position: Q2 2026 in Review

Citadel Advisors sold out of Alignment Healthcare (ALHC) in Q2 2026, closing a stake of 5,362,666 shares — an estimated $103M sold.

Citadel Advisors first reported a position in ALHC in Q2 2021 and held it in 18 quarters. The position peaked at $117M in Q2 2025. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Citadel Advisors reported no remaining Alignment Healthcare position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 5,362,666 Alignment Healthcare shares in Q2 2026, an estimated $103M.
  • Citadel Advisors first reported a position in Alignment Healthcare in Q2 2021 and held it in 18 quarters.
  • Citadel Advisors's Alignment Healthcare position peaked at $117M in Q2 2025.
  • 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.